识别Mi2的肌肉炎特异性自身抗体还准了共享PHD-指的自身免疫调节蛋白 (AIRE)
Jon Musai1, Sahana Jayaraman2, Katherine Pak1
1Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD, USA.
bioRxiv : the preprint server for biology
|June 26, 2025
概括
在皮肤肌炎中针对Mi2的自身抗体也识别了AIRE,这表明对基因调节至关重要的共享表位素. 这种交叉反应性可能解释了这些自身抗体如何破坏肌肉细胞中Mi2/NuRD复合体的功能.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 患有抗Mi2自身抗体的皮肤肌炎患者由于自身抗体与Mi2/NuRD复合物的干扰而表现出异常的基因表达.
- 这种干扰的确切机制和抗Mi2自身抗体的潜在交叉反应性仍然不清楚.
研究的目的:
- 在抗Mi2阳性患者中发现额外的自身抗体.
- 确定由抗Mi2和新型自身抗体识别的特定表位.
主要方法:
- 菌体免疫沉测序 (PhIP-Seq) 用于查患者血清中的自身抗体.
- 酶相关的免疫吸收试验 (ELISA) 和 luciferase 免疫沉系统 (LIPS) 免疫试验被用于验证.
主要成果:
- 在抗Mi2阳性患者中,PhIP-Seq确定了针对自身免疫调节器 (AIRE) 的自身抗体.
- 抗Mi2和抗AIRE自身抗体都识别了对蛋白质功能至关重要的同源植物主体指I型 (PHD1) 区域.
- 抗Mi2阳性患者经常表现出抗AIRE反应性,这在健康对照组和其他自身免疫性疾病中很少见.
结论:
- 识别Mi2的自身抗体还通过共享的PHD1域准AIRE,可能破坏Mi2/NuRD复合体的功能.
- 这种交叉反应性为抗Mi2自身抗体如何损害基因抑制提供了一种机制.
- 需要进一步的研究来探索与其他含有PHD1的蛋白质的结合和功能后果.
更多相关视频
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
Myocarditis II: Clinical Features and Diagnostic Tests
32
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
32
Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Myocarditis I: Introduction
36
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
36


